These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 24030132)

  • 1. Team-based approach to addressing simvastatin safety concerns.
    Robinson M; Gunning K; Pippitt K; McAdam-Marx C; Jennings BT
    J Am Pharm Assoc (2003); 2013; 53(5):539-44. PubMed ID: 24030132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of pharmacists' interventions and simvastatin dose restrictions.
    Shoulders BR; Franks AS; Barlow PB; Williams JD; Farland MZ
    Ann Pharmacother; 2014 Jan; 48(1):54-61. PubMed ID: 24259645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of prescriber responses to pharmacist recommendations communicated by fax in a medication therapy management program (MTMP).
    Perera PN; Guy MC; Sweaney AM; Boesen KP
    J Manag Care Pharm; 2011 Jun; 17(5):345-54. PubMed ID: 21657804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of medication-related problems and health care provider acceptance of pharmacist recommendations in the DiabetesCARE program.
    DeName B; Divine H; Nicholas A; Steinke DT; Johnson CL
    J Am Pharm Assoc (2003); 2008; 48(6):731-6. PubMed ID: 19019801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishing a clinical pharmacy technician at a United States Army military treatment facility.
    Evans JL; Gladd EM; Gonzalez AC; Tranam S; Larrabee JM; Lipphardt SE; Chen TT; Ronn MD; Spain J
    J Am Pharm Assoc (2003); 2016; 56(5):573-579.e1. PubMed ID: 27498312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simvastatin prescribing patterns before and after FDA dosing restrictions: a retrospective analysis of a large healthcare claims database.
    Tuchscherer RM; Nair K; Ghushchyan V; Saseen JJ
    Am J Cardiovasc Drugs; 2015 Feb; 15(1):27-34. PubMed ID: 25348907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective evaluation of medication appropriateness and clinical pharmacist drug therapy recommendations for home-based primary care veterans.
    Davis RG; Hepfinger CA; Sauer KA; Wilhardt MS
    Am J Geriatr Pharmacother; 2007 Mar; 5(1):40-7. PubMed ID: 17608246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of an automated dispensing system in outpatient pharmacies.
    Humphries TL; Delate T; Helling DK; Richardson B
    J Am Pharm Assoc (2003); 2008; 48(6):774-9. PubMed ID: 19019807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of pharmacists into a patient-centered medical home.
    Scott MA; Hitch B; Ray L; Colvin G
    J Am Pharm Assoc (2003); 2011; 51(2):161-6. PubMed ID: 21382805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration and compensation of pharmacists into primary care medical groups.
    Woodhouse A; Clements E; Keedy C; Presnell A; Schnibben A
    J Am Pharm Assoc (2003); 2019; 59(6):886-890. PubMed ID: 31521587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of simvastatin-amiodarone drug interaction alert on appropriate prescribing.
    Prom R; Umscheid CA; Kasbekar N; Spinler SA
    Am J Health Syst Pharm; 2013 Nov; 70(21):1878-9. PubMed ID: 24128959
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacist integration into the medical home: qualitative analysis.
    Kozminski M; Busby R; McGivney MS; Klatt PM; Hackett SR; Merenstein JH
    J Am Pharm Assoc (2003); 2011; 51(2):173-83. PubMed ID: 21382807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of pharmacy resident and student recommendations made before and after home-based primary care patient visits.
    Poon LH; Wang L; Moody S; Proffitt L
    Consult Pharm; 2015 Jan; 30(1):45-9. PubMed ID: 25591031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT).
    Hazen AC; Sloeserwij VM; Zwart DL; de Bont AA; Bouvy ML; de Gier JJ; de Wit NJ; Leendertse AJ
    BMC Fam Pract; 2015 Jul; 16():76. PubMed ID: 26135582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating pharmacogenomics into pharmacy practice via medication therapy management.
    Reiss SM;
    J Am Pharm Assoc (2003); 2011; 51(6):e64-74. PubMed ID: 22001957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organizational factors influencing pharmacy practice change.
    Doucette WR; Nevins JC; Gaither C; Kreling DH; Mott DA; Pedersen CA; Schommer JC
    Res Social Adm Pharm; 2012; 8(4):274-84. PubMed ID: 21958467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An off-site clinical pharmacy service in family medicine: development and 1-year outcomes.
    Vande Griend JP; Saseen JJ; Bislip D; Moore G; Conry C
    Fam Med; 2014 May; 46(5):348-53. PubMed ID: 24915477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in safety monitoring of biologic response modifiers after the implementation of clinical care guidelines by a specialty.
    Hanson RL; Gannon MJ; Khamo N; Sodhi M; Orr AM; Stubbings J
    J Manag Care Pharm; 2013; 19(1):49-67. PubMed ID: 23383700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacist engagement within a hepatitis C ambulatory care clinic in the era of a treatment revolution.
    Gauthier TP; Moreira E; Chan C; Cabrera A; Toro M; Carrasquillo MZ; Corentin M; Sherman EM
    J Am Pharm Assoc (2003); 2016; 56(6):670-676. PubMed ID: 27667501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacists' opportunities to reduce inappropriate prescription of QT-prolonging medications: calls to action.
    Dhanani TC; Mantovani EH; Turner JR
    Int J Pharm Pract; 2017 Apr; 25(2):176-179. PubMed ID: 27677250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.